Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 196 AL 210

Decoding the neuroprotective potential of hesperidin: Insights into Alzheimer's disease

Chauhan P, Vadia N, Ballal S, Joshi KK, Maharana L, Chauhan AS, Abomughaid MM, Lakhanpal S, Avinash D, Thakur K, Gupta R, Wadhwa K, Singh G, Jha NK.

Neuroscience. 2025 Nov 28;589:205-220. doi: 10.1016/j.neuroscience.2025.09.028. Epub 2025 Sep 20.

Targeting the glymphatic system: Aβ accumulation and phototherapy strategies across different stages of Alzheimer's disease

Zhao D, Wang J, Zhu Y, Zhang H, Ni C, Zhao Z, Dai J, He R, Liu G, Gan C, Zhang S, Tong Z.

Transl Neurodegener. 2025 Sep 24;14(1):49. doi: 10.1186/s40035-025-00510-8.

Synbiotics in Alzheimer's disease: mechanisms, clinical evidence, and therapeutic prospects

Lin Y, Weng R, Pan H, Hou Y, Sun Y, Wen J.

J Transl Med. 2025 Sep 24;23(1):1009. doi: 10.1186/s12967-025-07064-3.

Treatment for Alzheimer's disease

Fox NC, Belder C, Ballard C, Kales HC, Mummery C, Caramelli P, Ciccarelli O, Frederiksen KS, Gomez-Isla T, Ismail Z, Paquet C, Petersen RC, Perneczky R, Robinson L, Sayin O, Frisoni GB.

Lancet. 2025 Sep 27;406(10510):1408-1423. doi: 10.1016/S0140-6736(25)01329-7. Epub 2025 Sep 22.

Alzheimer's disease outlook: controversies and future directions

Frisoni GB, Aho E, Brayne C, Ciccarelli O, Dubois B, Fox NC, Frederiksen KS, Gabay C, Garibotto V, Hofmarcher T, Jack CR Jr, Kivipelto M, Petersen RC, Ribaldi F, Rowe CC, Walsh S, Zetterberg H, Hansson O.

Lancet. 2025 Sep 27;406(10510):1424-1442. doi: 10.1016/S0140-6736(25)01389-3. Epub 2025 Sep 22.

From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease

Raza A, Saleem S, Imran S, Rahman S, Haroon M, Razzaq A, Hussain A, Iqbal J, Sathian B.

Metab Brain Dis. 2025 Sep 26;40(7):276. doi: 10.1007/s11011-025-01700-z.

The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer's Disease: Mechanisms and Therapeutic Potential

Abdol Samat HN, Razali NN, Mahadzir H, Tengku Muhammad TS, Ling KH, Mansor NI, Abidin SZ.

Int J Mol Sci. 2025 Sep 12;26(18):8905. doi: 10.3390/ijms26188905.

Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer's Disease and HIV-Associated Neurocognitive Disorders

Njoku GC, Kanmogne GD.

Int J Mol Sci. 2025 Sep 17;26(18):9069. doi: 10.3390/ijms26189069.

Targeting the awry Aβ pathway in Alzheimer's disease: hype and hurdles

Al-Kuraishy HM, Sulaiman GM, Al-Gareeb AI, Mohammed HA, Albuhadily AK, Abomughaid MM.

Inflammopharmacology. 2025 Oct;33(10):5945-5961. doi: 10.1007/s10787-025-01983-9. Epub 2025 Sep 27.

BNIP3L/NIX-mediated mitophagy: Future directions in Alzheimer's disease

Kakoty V, Goh KW, Kesharwani P, Ko YT.

Brain Res. 2025 Nov 15;1867:149970. doi: 10.1016/j.brainres.2025.149970. Epub 2025 Sep 27.

Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers

Schreiber CP, Kovacik A, Bishop J, Helman J.

Drugs Aging. 2025 Dec;42(12):1103-1111. doi: 10.1007/s40266-025-01253-x. Epub 2025 Oct 3.

TDP-43 in Alzheimer's disease: Pathophysiology and therapeutic strategies

Zhou X, Lin X, He Y, Huang N, Luo Y.

Pharmacol Res. 2025 Nov;221:107977. doi: 10.1016/j.phrs.2025.107977. Epub 2025 Oct 4.

Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer's disease

Fan X, Wang H, Ping J, Li M, Gu J, Qian W.

Biochem Pharmacol. 2025 Dec;242(Pt 3):117401. doi: 10.1016/j.bcp.2025.117401. Epub 2025 Oct 3.

lncRNA EPB41L4A-AS1: A promising therapeutic target for aging and age-related diseases

Li M, Li T, Zhang X, Li K, Wang Z.

Mech Ageing Dev. 2025 Dec;228:112118. doi: 10.1016/j.mad.2025.112118. Epub 2025 Oct 9.

Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer's disease

Amniouel S, Suh J, Zheng W, Zhang Q.

Transl Neurodegener. 2025 Oct 13;14(1):51. doi: 10.1186/s40035-025-00513-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias